A study in the relationships between leptin, insulin, and body fat in Asian subjects

International Journal of Obesity

Volumn 23, Issue 3, 1999, Pages 246-252

  Ho, S C ^a   Tai, E S ^a   Eng, P H K ^a   Ramli, A ^a   Tan, C E ^a   Fok, A C K ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Body fat distribution; Insulin resistance; Leptin; Lipid profile; Obesity

Indexed keywords

CHOLESTEROL; INSULIN; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; ASIAN; BLOOD PRESSURE; BODY FAT; BODY HEIGHT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; IMPEDANCE; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE;

BIA;

EID: 0033020552     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800801     Document Type: Article

References (45)

1. 1 Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, MacKellar W, Rosteck PR, Schoner B, Smith D, Tinsley FC, Xhang XY, Heman M. The role of neuropeptide y in the anti-obesity action of the obese gene product. Nature 1995; 377: 530-532.
2. 2 Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-431.
3. 3 Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-542.
4. 4 Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269: 543-545.
5. 5 Streamson CC, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, Leibel RL. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996; 271: 994-996.
6. 6 Campfield LA, Smith FJ, Guises Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-549.
7. 7 Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387: 903-908.
8. 8 Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD. A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998; 18: 213-215.
9. 9 Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. Serum Immunoreactive leptin concentrations in normal-weight and obese humans. NEJM 1996; 334: 292-324.
10. 10 Ryan AS, Elahi D. The effects of acute hyperglycemia and hyperinsulinemia on plasma leptin levels: Its relationships with body fat, visceral adiposity and age in women. JCEM 1996; 81: 4433-4438.
11. 11 Havel PJ, Kasim-Karakas S, Mueller W, Johnson PR, Gingerich RL, Stern JS. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. JCEM 1996; 81: 4406-4413.
12. 12 Ostlund RE, Yang JW, Klein S, Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age and metabolic covariates. JCEM 1996; 81: 3909-3913.
13. 13 Wabitsch M, Blum WF, Muche R, Braun M, Hube F, Rascher W, Heinze E, Teller W, Hauner H. Contribution of androgens to the gender difference in leptin production in obese children and adolescents. J Clin Invest 1997; 100: 808-813.
14. 14 Chapman IM, Wittert GA, Norman RJ. Circulating leptin concentrations in polycystic ovary syndrome: Relation to anthropometric and metabolic parameters. Clin Endocrinol 1997; 46: 175-181
15. 15 Saladin R, De Vos P, Geurre-Millo M, Leturque A, Girard J, Straels B, Auwerx J. Transient increase in obese gene expression after food intake or insulin administration. Nature 1995; 377: 527-529.
16. 16 Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D, Woods SC, Seeley RJ, Weigle DS. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide y gene expression in ob/ob mice. Diabetes 1996; 45: 531-535.
17. 17 Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
18. 18 Nyholm B, Fisker S, Lund S, Moller N, Schmitz O. Increased circulating leptin concentrations in insulin-resistant first-degree relatives of patients with non-insulin dependent diabetes mellitus: Relationship to body composition and insulin sensitivity but not to family history of non-insulin dependent diabetes mellitus. Eur J Endocrinol 1997; 136: 173-179.
19. 19 Larsson H, Elmstahl S, Ahren B. Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women. Diabetes 1996; 45: 1580-1584.
20. 20 Larsson H, Ahren B. Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women. JCEM 1996; 81: 4428-4432.
21. 21 Pratley RE, Nicolson M, Bogardus C, Ravussin E. Effects of acute hyperinsulinemia on plasma leptin concentrations in insulin-sensitive and insulin-resistant Pima Indians. JCEM 1996; 81: 4418-4421.
22. 22 Reaven GM, Chen YDI, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinaemia in individuals with small dense, low density lipoprotein particles. J Clin Invest 1993; 92: 141-146.
23. 23 Lindahl B, Asplund K, Hallmans G. High serum insulin, insulin resistance and their associations with cardiovascular risk factors. The Northern Sweden MONICA population study. J Int Med 1993; 234: 263-270.
24. 24 Campos H, Bailey SM, Gussak LS, Siles X, Ordovas JM, Schaefer EJ. Relations of body habits, fitness level and cardiovascular risk factors including lipoproteins and apolipoproteins in a rural and urban Costa Rican population. Arteriosclerosis and Thrombosis 1991; 11: 1077-1088.
25. 25 Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectric impedence measurement of the human body. Am J Clin Nutr 1985; 41: 410-414.
26. 26 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-419.
27. 27 Tan CE, Emmanuel SC, Tan BY, Jacob E. Prevalence of diabetes mellitus and ethnic differences in cardiovascular risk factors; The 1992 Singapore National Health Survey. Diabetes Care (in press).
28. 28 Shimizu H, Shimomura Y, Hayashi R, Ohtani K, Sato N, Futawatari T, Mori M. Serum leptin concentration is associated with total body fat mass, but not abdominal fat distribution. Int J Obes 1997; 21: 536-541.
29. 29 Motoyama HK, Yamaguchi T, Katakura T, Miura M, Ohashi Y, Yazaki Y, Kadawaki T. Serum leptin levels are associated with hyperinsulinemia independent of body mass index but not visceral obesity. Biochem Biophys Res Commun 1997; 239: 340-344.
30. 30 Ramachandran A, Snehalatha C, Vijay V, Satyavani K, Latha E, Haffher SM. Plasma leptin in non-diabetic Asian Indians: Association with abdominal adiposity. Diabet Med 1997; 14: 937-941
31. 31 Takahashi M, Funahashi T, Shimomura I, Miyaoka K, Matsuzawa Y. Plasma leptin levels and body fat distribution. Horm Metab Res 1996; 28: 751-752.
32. 32 Slieker LJ, Sloop KW, Surface PL, Kriaucinunas A, LaQuier F, Manetta J, Bue-Valleskey J, Stephens TW. Regulation of expression of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem 1996; 271: 5301-5304.
33. 33 Kolaczynski JW, Nyce MR, Considine RV. Acute and chronic effects of insulin on leptin production in humans. Studies in vivo and in vitro. Diabetes 1996; 45: 699-701.
34. 34 Vidal H, Auboeuf D, Vos PD, Staels B, Rious JP, Auwerx J, Laville M. The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaenous adipose tissue. J Clin Invest 1996; 98: 251-255.
35. 35 Zimmet P, Hodge A, Nicolson M, Staten M, de Courten M, Moore J, Moraawiecki A, Lubina J, Collier G, Alberti G, Dowse G. Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. BMJ 1997; 313: 965-969.
36. 36 Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 1997; 46: 342-347.
37. 37 Saad MF, Damani S, Gingerich RL, Riad-Gabriel MG, Khan A, Boyadjian R, Jinagouda SD, El-Tawil K, Rude RK, Kamdar V. Sexual dimorphism in plasma leptin concentration. JCEM 1997; 82: 579-584.
38. 38 Haffner SM, Gingerich RL, Miettinen H, Stern MP. Leptin concentrations in relation to overall adiposity and regional body fat distributio in Mexican Americans. Int J Obes 1996; 20: 904-908.
39. 39 Bjorntorp P. Regional obesity. In: Bjorntorp P, Brodoff BN (eds). Obesity. Lippincott: Philadelphia, 1992, 579-586.
40. 40 Hube F, Lietz U, Igel M, Jensen PB, Tornqvist H, Joost HG, Hauner H. Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Horm Metab Res 1996; 28: 690-693.
41. 41 Lonnqvist F, Wennlund A, Arner P. Relationship between circulating leptin and peripheral fat distribution in obese subjects. Int J Obes 1997; 21: 255-260.
42. 42 Barter PJ, Rye KA. High-density lipoproteins and coronary heart disease. Atherosclerosis 1996; 121: 1-12.
43. 43 Austin MA. Plasma triglyceride and coronary heart disease. Arteriosclerosis and Thrombosis 1991; 11: 2.
44. 44 Austin MA, Breslow JL, Hennekens CH, Buring JE, Willet WC, Krauss RM. Low density lipoprotein subclass and risk of myocardial infarction. JAMA 1988; 260: 1917-1921.
45. 45 Griffin B, Freeman D, Tait G, Thomson J, Caslake M, Packard C. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small dense LDL to coronary artery disease. Atherosclerosis 1994; 106: 241-253.